Literature DB >> 30090558

Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs.

Yaqing Wang1,2, Wentao Su1, Li Wang1, Lei Jiang1, Yang Liu1,2, Lijian Hui2,3, Jianhua Qin1,2.   

Abstract

Preservation of hepatic phenotype and functions in vitro has always been a great challenge for the reconstruction of liver tissue engineering and in pharmaceutical research studies. Human induced hepatocytes (hiHeps) generated from fibroblasts can be reproducible with almost normal levels of liver specific functions, which are considered as a new source of hepatocytes for biomedical applications. Moreover, paper has served as an attractive biocompatible material for cell-based applications. In this study, we established a simple paper-based scaffold array for creating a 3D liver co-culture model that enabled the assessment of drug induced hepatotoxicity. The hiHeps co-cultured with HUVECs exhibited a 3D like morphology and maintained the liver specific functions of producing albumin and urea for up to 2 months. In addition, the hiHeps in this co-cultured model maintained a higher expression of cytochrome P450 genes as compared with a monolayer culture on a plate and a single culture on paper of hiHeps, revealing a marked enhancement of hepatic functions in the 3D liver co-culture model. Moreover, the 3D liver co-culture model was exposed to acetaminophen (APAP) and pioglitazone, exhibiting near physiological hepatotoxic responses compared to those of the monolayer cultures. Taken together, the low-cost and bioactive paper scaffold could offer great opportunities as 3D in vitro platforms for tissue engineering applications and high-throughput drug testing.

Entities:  

Year:  2017        PMID: 30090558      PMCID: PMC6061007          DOI: 10.1039/c7tx00209b

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  37 in total

Review 1.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

2.  Paper-based microreactor integrating cell culture and subsequent immunoassay for the investigation of cellular phosphorylation.

Authors:  Kin Fong Lei; Chia-Hao Huang
Journal:  ACS Appl Mater Interfaces       Date:  2014-12-03       Impact factor: 9.229

3.  Controlled formation of heterotypic hepatic micro-organoids in anisotropic hydrogel microfibers for long-term preservation of liver-specific functions.

Authors:  Masumi Yamada; Rie Utoh; Kazuo Ohashi; Kohei Tatsumi; Masayuki Yamato; Teruo Okano; Minoru Seki
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

4.  Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects.

Authors:  Seung-A Lee; Da Yoon No; Edward Kang; Jongil Ju; Dong-Sik Kim; Sang-Hoon Lee
Journal:  Lab Chip       Date:  2013-09-21       Impact factor: 6.799

5.  Paper-based bioactive scaffolds for stem cell-mediated bone tissue engineering.

Authors:  Hyun-Ji Park; Seung Jung Yu; Kisuk Yang; Yoonhee Jin; Ann-Na Cho; Jin Kim; Bora Lee; Hee Seok Yang; Sung Gap Im; Seung-Woo Cho
Journal:  Biomaterials       Date:  2014-09-17       Impact factor: 12.479

Review 6.  Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation.

Authors:  E L LeCluyse
Journal:  Eur J Pharm Sci       Date:  2001-07       Impact factor: 4.384

7.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes.

Authors:  Pengyu Huang; Ludi Zhang; Yimeng Gao; Zhiying He; Dan Yao; Zhitao Wu; Jin Cen; Xiaotao Chen; Changcheng Liu; Yiping Hu; Dongmei Lai; Zhenlei Hu; Li Chen; Ying Zhang; Xin Cheng; Xiaojun Ma; Guoyu Pan; Xin Wang; Lijian Hui
Journal:  Cell Stem Cell       Date:  2014-02-27       Impact factor: 24.633

8.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

Authors:  Stefan Wilkening; Frank Stahl; Augustinus Bader
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

9.  Long-term maintenance of a microfluidic 3D human liver sinusoid.

Authors:  Ljupcho Prodanov; Rohit Jindal; Shyam Sundhar Bale; Manjunath Hegde; William J McCarty; Inna Golberg; Abhinav Bhushan; Martin L Yarmush; Osman Berk Usta
Journal:  Biotechnol Bioeng       Date:  2015-08-26       Impact factor: 4.530

10.  Three-dimensional paper-based model for cardiac ischemia.

Authors:  Bobak Mosadegh; Borna E Dabiri; Matthew R Lockett; Ratmir Derda; Patrick Campbell; Kevin Kit Parker; George M Whitesides
Journal:  Adv Healthc Mater       Date:  2014-02-12       Impact factor: 9.933

View more
  4 in total

1.  An AC electrothermal self-circulating system with a minimalist process to construct a biomimetic liver lobule model for drug testing.

Authors:  Shengli Mi; Baihan Li; Xiaoman Yi; Yuanyuan Xu; Zhichang Du; Shuaitao Yang; Wei Li; Wei Sun
Journal:  RSC Adv       Date:  2018-11-01       Impact factor: 4.036

Review 2.  Current strategies with implementation of three-dimensional cell culture: the challenge of quantification.

Authors:  Jonathan Temple; Eirini Velliou; Mona Shehata; Raphaël Lévy
Journal:  Interface Focus       Date:  2022-08-12       Impact factor: 4.661

Review 3.  Physiologically relevant microsystems to study viral infection in the human liver.

Authors:  Dennis McDuffie; David Barr; Ashutosh Agarwal; Emmanuel Thomas
Journal:  Front Microbiol       Date:  2022-09-28       Impact factor: 6.064

Review 4.  Liver microsystems in vitro for drug response.

Authors:  Jyong-Huei Lee; Kuan-Lun Ho; Shih-Kang Fan
Journal:  J Biomed Sci       Date:  2019-10-28       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.